Corrigendum to “LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease” BBAPAP 1865 (6) (2017) 703–714

Publication date: Available online 9 February 2018 Source:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Author(s): A. Schrötter, A. Oberhaus, K. Kolbe, S. Seger, T. Mastalski, F. El Magraoui, E. Hoffmann-Posorske, M. Bohnert, J. Deckert, C. Braun, M. Graw, C. Schmitz, T. Arzberger, C. Loosse, H. Heinsen, H.E. Meyer, T. Müller
Source: Biochimica et Biophysica Acta (BBA) Proteins and Proteomics - Category: Biochemistry Source Type: research

Related Links:

Conclusion: the family caregivers of elderly people with Alzheimer ’ s disease experience difficulties in the physical, mental and social aspects, for which they develop/use gerontechnologies in the form of products and processes/knowledge/strategies, to assist them in the care/coexistence with the elderly person with Alzheimer ’ s disease.
Source: Texto e Contexto - Enfermagem - Category: International Medicine & Public Health Source Type: research
Publication date: Available online 12 December 2018Source: NeuroImage: ClinicalAuthor(s): Meiyan Huang, Chunyan Deng, Yuwei Yu, Tao Lian, Wei Yang, Qianjin Feng, the Alzheimer's Disease Neuroimaging InitiativeAbstractPotential biomarker detection is a crucial area of study for the prediction, diagnosis, and monitoring of Alzheimer's disease (AD). The voxelwise genome-wide association study (vGWAS) is widely used in imaging genomics studies that is usually applied to the detection of AD biomarkers in both imaging and genetic data. However, performing vGWAS remains a challenge because of the computational complexity of the t...
Source: NeuroImage: Clinical - Category: Radiology Source Type: research
ABSTRACT Protein misfolding diseases are usually associated with deposits of single “ key ” proteins that somehow drive the pathology; β -amyloid and hyperphosphorylated tau accumulate in Alzheimer's disease, α -synuclein in Parkinson's disease, or abnormal prion protein (PrPTSE) in transmissible spongiform encephalopathies (TSEs or prion diseases). However, in some diseases more than two proteins accumulate in the same brain. These diseases might be considered “ complex ” proteinopathies. We have studied models of TSEs (to explore deposits of PrPTSE and of “ secondary proteins &rdq...
Source: Arquivos de Neuro-Psiquiatria - Category: Neurology Source Type: research
Many people have told me how difficult they find it to visit friends and family who have Alzheimer ’s and dementia.By Marilyn RaichleAlzheimer's Reading Room“We have nothing to talk about. I don’t know what to say.”“It’s so sad – she is everything she never wanted to be.”“She would hate this so much. This was her worst nightmare.”So the pattern begins...Subscribe to the Alzheimer's Reading RoomEmail:Visiting makes you sad or uncomfortable,so you don ’t visit.Not visiting makes you feel guilty, so you put off visiting again.“She won’t remember it ...
Source: Alzheimer's Reading Room, The - Category: Neurology Tags: alzheimer s alzheimers care alzheimers caregiving Alzheimers Dementia Alzheimers Disease alzheimers information dementia care health memory memory loss Source Type: blogs
DiscussionOur observations suggest that PART is separate from AD and its distinction will be important for the clinical management of patients with cognitive impairment and for public health care planning.
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Condition:   Dementia Intervention:   Behavioral: IN-PEACE Dementia Care Coordination Sponsors:   Indiana University;   Regenstrief Institute, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The simple fact is many Alzheimer's patients don't like water because they no longer perceive water in the way that you and I do.By Bob DeMarcoAlzheimer's Reading RoomWater is nearly invisible and often disconcerting to the typical Alzheimer's patient. They don't like to drink it, and they don't like to take a shower or bath in it.What is the Difference Between Alzheimer ’s and DementiaWe often discuss how difficult it is to get an Alzheimer's patients or a patient with a related dementia to take abath.Subscribe to the Alzheimer's Reading RoomEmail:Carole Larkin estimates thatbathing is one of the top three prob...
Source: Alzheimer's Reading Room, The - Category: Neurology Tags: alzheimer's awareness alzheimer's care Alzheimer's Dementia dementia care dementia help for caregivers help alzheimer's help with dementia care memory care searches related to dementia care Source Type: blogs
Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer's disease and other neurodegenerative diseases. AC Immune to receive an initial upfront payment of CHF80 million and will be eligible for CHF6... Biopharmaceuticals, Neurology, Licensing Eli Lilly, AC Immune, Morphomer tau aggregation, Alzheimer's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
U.S. drugmaker Eli Lilly&Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Authors: Mitolo M, Tonon C, La Morgia C, Testa C, Carelli V, Lodi R Abstract BACKGROUND: Bright light treatment is a therapeutic intervention mainly used to treat sleep and circadian disturbances in Alzheimer's disease (AD) patients. Recently, a handful of studies also focused on the effect on cognition and behavior. Conflicting findings are reported in the literature, and no definite conclusions have been drawn about its specific therapeutic effect. SUMMARY: The aim of this review is to provide a critical evaluation of available evidence in this field, highlighting the specific characteristics of effective bri...
Source: Dementia and Geriatric Cognitive Disorders - Category: Psychiatry Tags: Dement Geriatr Cogn Disord Source Type: research
More News: Alzheimer's | Biochemistry